1988
DOI: 10.1016/0006-8993(88)91570-3
|View full text |Cite
|
Sign up to set email alerts
|

GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
34
0
1

Year Published

1990
1990
2008
2008

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 95 publications
(37 citation statements)
references
References 27 publications
2
34
0
1
Order By: Relevance
“…However, this result is supported by previous studies performed in animals and humans. In animals, BZDs have been shown to antagonise opioid analgesia [15,16], and in humans the BZD antagonist flumazenil has been shown to enhance Anaesthesia ...................................................................................................................................................................................................................…”
Section: Discussionmentioning
confidence: 99%
“…However, this result is supported by previous studies performed in animals and humans. In animals, BZDs have been shown to antagonise opioid analgesia [15,16], and in humans the BZD antagonist flumazenil has been shown to enhance Anaesthesia ...................................................................................................................................................................................................................…”
Section: Discussionmentioning
confidence: 99%
“…The exact mechanism through which this occurs remains unknown, although the inhibitory neurotransmitter GABA appears to play a major role (Asana and Ogasawara 1981;Olsen and Snowman 1982;Sivam et al 1982). For example, activation of GABA receptors in the NRM was shown to increase responses to noxious stimuli (Drower and Hammond 1988). Pentobarbital may bind to GABA receptors in the NRM, resulting in a disinhibition of systems necessary for pain modulation.…”
Section: Discussionmentioning
confidence: 99%
“…To achieve this, barbiturates bind at the GABA-A receptor increasing the opening time of chloride channels, thus permitting chloride ion entry into the cells (4). In addition, activation of the GABA-A receptor has been associated with pain modulation in the central nervous system (CNS), essentially through the descending inhibitory system (5). However, it is still a matter of discussion in the literature whether barbiturates increase (6,7) or decrease (8,9) the pain threshold.…”
Section: Introductionmentioning
confidence: 99%
“…Some studies have shown that the site of barbiturate binding is close to the site of the neurotransmitter binding in the GABA-A receptor (4,5). On the other hand, the picrotoxin site is inside the channel where it seems to inhibit the entry of the chloride ions into the cell (24).…”
mentioning
confidence: 99%